Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

LUSIGNAN

Showing results (581-590 of 628) with videos related to

Pageof 63
Sort By:
Journal of the Royal Society of Medicine|November 3, 2023
Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series studyRuby Sm Tsang, Utkarsh Agrawal, Mark Joy, et al.
Vaccine|November 6, 2019
End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19Richard G Pebody, Heather Whitaker, Joanna Ellis, et al.
The Lancet Regional Health. Europe|January 1, 2024
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and WalesStuart Bedston, Fatima Almaghrabi, Lynsey Patterson, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 20, 2022
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trialJienchi Dorward, Ly-Mee Yu, Gail Hayward, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 8, 2019
End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18Richard Pebody, Abdelmajid Djennad, Joanna Ellis, et al.
The Lancet. Respiratory Medicine|July 30, 2021
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialChristopher C Butler, Ly-Mee Yu, Jienchi Dorward, et al.
Hypertension (Dallas, Tex. : 1979)|December 16, 2020
Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension: An Observational Cohort StudyJames P Sheppard, Brian D Nicholson, Joseph Lee, et al.
JMIR Research Protocols|January 22, 2025
Clinical Characteristics of Virologically Confirmed Respiratory Syncytial Virus in English Primary Care: Protocol for an Observational Study of Acute Respiratory InfectionUy Hoang, Utkarsh Agrawal, José Manuel Ordóñez-Mena, et al.
The Journal of Infection|August 29, 2020
Disparities in the excess risk of mortality in the first wave of COVID-19: Cross sectional study of the English sentinel networkSimon de Lusignan, Mark Joy, Jason Oke, et al.
JMIR Public Health and Surveillance|April 3, 2020
Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health EnglandSimon de Lusignan, Jamie Lopez Bernal, Maria Zambon, et al.
Pageof 63

Showing results (581-590 of 628) with videos related to

Sort By:
Pageof 63
Journal of the Royal Society of Medicine|November 3, 2023
Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series studyRuby Sm Tsang, Utkarsh Agrawal, Mark Joy, et al.
Vaccine|November 6, 2019
End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19Richard G Pebody, Heather Whitaker, Joanna Ellis, et al.
The Lancet Regional Health. Europe|January 1, 2024
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and WalesStuart Bedston, Fatima Almaghrabi, Lynsey Patterson, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 20, 2022
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trialJienchi Dorward, Ly-Mee Yu, Gail Hayward, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 8, 2019
End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18Richard Pebody, Abdelmajid Djennad, Joanna Ellis, et al.
The Lancet. Respiratory Medicine|July 30, 2021
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialChristopher C Butler, Ly-Mee Yu, Jienchi Dorward, et al.
Hypertension (Dallas, Tex. : 1979)|December 16, 2020
Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension: An Observational Cohort StudyJames P Sheppard, Brian D Nicholson, Joseph Lee, et al.
JMIR Research Protocols|January 22, 2025
Clinical Characteristics of Virologically Confirmed Respiratory Syncytial Virus in English Primary Care: Protocol for an Observational Study of Acute Respiratory InfectionUy Hoang, Utkarsh Agrawal, José Manuel Ordóñez-Mena, et al.
The Journal of Infection|August 29, 2020
Disparities in the excess risk of mortality in the first wave of COVID-19: Cross sectional study of the English sentinel networkSimon de Lusignan, Mark Joy, Jason Oke, et al.
JMIR Public Health and Surveillance|April 3, 2020
Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health EnglandSimon de Lusignan, Jamie Lopez Bernal, Maria Zambon, et al.
Pageof 63